Lipoprotein X in the Setting of COVID-19–Induced Cholangiopathy: An Unforeseen Event-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipoprotein X in the Setting of COVID-19–Induced Cholangiopathy: An Unforeseen Event

Published:2024-01-01 Issue:1 Volume:3 Page:
ISSN:2767-7672
Container-title:Annals of Internal Medicine: Clinical Cases
language:en
Short-container-title:AIM Clinical Cases

Author:

Patel Hardik¹^ORCID,Berglund Felix²,Lindenmeyer Christina C.³^ORCID,Ruthmann Nicholas²

Affiliation:

1. Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio

2. Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio

3. Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio

Publisher

American College of Physicians

Link

https://www.acpjournals.org/doi/pdf/10.7326/aimcc.2023.0813

Reference10 articles.

1. Ashorobi D, Liao H. Lipoprotein X induced hyperlipidemia. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023.

2. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease

3. Hypercholesterolemia After COVID-19: Time to Include Lipoprotein X Among the Differential Diagnoses

4. Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review

5. Lipoprotein-X fifty years after its original discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP